Solutions

Solutions

Our solutions span the entire lifecycle of product development and commercialisation, and can be adapted to suit small local trials or large global programs.

Read more

Cardiac Safety Solutions Clinical & Scientific Operations Consulting Early Clinical Laboratories Language Services Medical Imaging Site & Patient Solutions Strategic Solutions Symphony Health Technologies

Decentralised Clinical Trial Solutions
End-to-end services, operational model and technology to deliver customised solutions.

Real World Intelligence®
Optimising real world data to drive effective outcomes and achieve regulatory authorisation.
Sectors

Sectors

ICON provides its full range of clinical, consulting and commercial services across several industry sectors.

Read more

Biotech Government and Public Health Medical Device Pharmaceuticals

Biotech
Developing transformative therapies requires a flexible approach.

ICON and You
Partners making a difference.
Therapeutics

Therapeutics

Cardiovascular Central Nervous System Endocrine & Metabolic Disorders Infectious Diseases Internal Medicine & Immunology Oncology

Cross-therapeutics

Biosimilars Cell and Gene Therapies Medical Device Paediatrics Rare & Orphan Diseases Vaccines Women's Health

Obesity
A focus on combination therapies requires appropriate obesity-specific trial designs, long-term follow-up studies and diverse patient recruitment.

Therapeutics insights
ICON's therapeutic experts contribute regularly to industry publications and the creation of thought leadership content. Read more.
Insights

Insights

Digital Disruption Patient Centricity Regulatory Intelligence Therapeutics insights Transforming Trials Value Based Healthcare Blog Videos Webinar Channel

Embracing a blended operating model
Maximising efficiency and flexibility with custom outsourcing.

De-risking clinical development of precision medicines in oncology
An evolving understanding of cancer biology has resulted in the rise of precision-informed treatment approaches.

Strategies for commercialising oncology treatments for young adults
Oncology treatments tailored specifically for young adults.
News & Events

News & Events

ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.

Read more

Press releases In the News Mediakit Awards Events Webinars Social media

Webinar: Unlocking precision medicine: An overview of Illumina’s TSO500
17 June 2024

Webinar: Ensuring patient recruitment success at a site level
09 July 2024
About ICON

About ICON

Our mission is to help clients accelerate the development of drugs and devices that save lives and improve quality of life.

Read more

Company history Healthcare Intelligence ICON in Asia Pacific ICON in Latin America Leadership Quality

Environmental, Social and Governance
ICON CARES is our commitment to making a positive impact on our people, environment and our community.

Healthcare Intelligence
Clinical Research. Evolved.

Careers
Investors
Investigators
Patients
Contact

Home
Insights
ICON Webinar Channel

ICON Webinar Channel

Home
Clinical Research Services
Commercialisation & Outcomes
Early Phase
Laboratory Webinars
Medical Device
Therapeutic Webinars

Panel Session: Bioanalysis zone

55:42

Share on Facebook
Share on X
Share on LinkedIn
Share via Email

Description

Share

Share on Facebook
Share on X
Share on LinkedIn
Share via Email

Related Videos

In Laboratory Webinars

Play video Multi-diagnostic approaches for patient selection biomarkers in immuno-oncology

Multi-diagnostic approaches for patient selection biomarkers in immuno-oncology

28:23
Play video Webinar: Singlicate ADA analysis

Webinar: Singlicate ADA analysis

36:23
Play video Best practices for the validation of hybrid LC-MS/MS assays

Best practices for the validation of hybrid LC-MS/MS assays

55:01
Play video Panel discussion: Immunogenicity assessment of therapeutic proteins

Panel discussion: Immunogenicity assessment of therapeutic proteins

56:37
Play video NASH Clinical Trials: Challenges and Considerations

NASH Clinical Trials: Challenges and Considerations

Dr. Andrew Roche discusses overcoming the challenges and considerations associated with NASH Clinical Trials and examination of potential strategies to address during trial design or study execution.

46:50
Play video Best practices for laboratory solutions relating to Cell and Gene Therapy clinical trials

Best practices for laboratory solutions relating to Cell and Gene Therapy clinical trials

1:01:13

Contact
About ICON
Results & Reports

For Clients

Therapeutics
Solutions
Insights
Technologies
Content preferences
Office locations

ICON for

Patients
Volunteers
Investigators
Jobs & Careers
Investors
Suppliers

News & Events

Press releases
Mediakit
Events
Social media dashboard

LinkedIn
Twitter
Facebook
Instagram
Youtube

Disclaimer
Privacy & Data
Cookies

Share this video

Embed

Size: x pixels

Solutions

Sectors

News & Events

About ICON

ICON Webinar Channel

Panel Session: Bioanalysis zone

Share

Related Videos

In Laboratory Webinars

Multi-diagnostic approaches for patient selection biomarkers in immuno-oncology

Webinar: Singlicate ADA analysis

Best practices for the validation of hybrid LC-MS/MS assays

Panel discussion: Immunogenicity assessment of therapeutic proteins

NASH Clinical Trials: Challenges and Considerations

Best practices for laboratory solutions relating to Cell and Gene Therapy clinical trials

Share this video

Embed